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Objective: To determine the relationship between biofilm formation by Pseudomonas aeruginosa (PAE) and 
its antimicrobial resistance and efflux pumps overexpression (EPO). 
Methods: A total of 112 PAE strains from a hospital in Lima (Peru) were used. Biofilm formation was 
determined by microtiter-plate test. Biofilm producing phenotype (BPP) was classified as strong biofilm 
producer (SBP), moderate biofilm producer (MBP), weak biofilm producer (WBP) and non biofilm producer 
(NBP) following the Stepanovic´s criteria. The susceptibility to beta-lactam, aminoglycosides and 
fluoroquinolones was determined by disk diffusion. Levofloxacin (LVX) MIC was established in the 
presence and absence of 20 µg/mL of Phe-Arg-β-naphthylamide (PAßN). EPO was considered when PAßN 
enhanced LVX activity ≥2-fold. MDR was defined as resistance to three or more unrelated antibiotics. 
Results: Of the 112 PAE isolates, 99% (111/112) were BPP being classified as SBP (57;50.8%), MBP 
(45;40.1%), WBP (9;8.0%) and NBP (1;0.89%). The SBP isolates showed significant high levels of 
antimicrobial resistance, that MBP and WBP excepting Aztreonam (p=0,15) and Ofloxacin (p= 0,41). Fifty 
isolates showed EPO phenotype, from this 58% (29/50) were SBP, 36% (18/50) were MBP and 4% and 2% 
(2/50 and 1/50 respectively) were WBP and NBP, but no significant differences were observed. Of the 
isolates with BPP, the 45% (50/111) were MDR and 58% of them, were observed as SBP (31/50, p=0,04).  
Conclusion: Almost all PAE isolates possess BPP. Moreover, a strong relationship between the antimicrobial 
resistance and the SBP phenotype was observed. Despite the trend of EPO isolates to be SBP no statistic 
association was observed. 
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Distinct availabilities of oxygen, nutrients and antibiotics in the cystic fibrosis (CF) airways have contributed 
to the colonization of a large polymicrobial community, which may have further repercussion in the 
development of chronic biofilms and in antibiotherapy. This study aimed to inspect whether CF-related 
bacteria - Staphylococcus aureus (Sa) and two less common species Acinetobacter baumanni (Ab) and 
Klebsiella pneumoniae (Kp), are able to develop in vitro biofilms and resist to ciprofloxacin under 
aerobic/hypoxic conditions. Thus, biofilm-cells were estimated by CFU counting and time-kill-curves 
determined by absorbance (planktonic) and CFU (biofilm). All species showed alike results for biofilm 
growth, with higher bacteria (~109 CFU/cm2) adhering under aerobiosis than for hypoxic atmospheres 
(~108 CFU/cm2) in 24 h. Regarding the susceptibility profiles, Sa was the most sensitive species 
(MIC/MBC: 0.5 mg/L), with Kp keeping the most resistant profile against ciprofloxacin (MIC: 16 mg/L; 
MBC: >512 mg/L). Planktonic and biofilm time-kill curves were equivalent for both atmospheres. 
Interestingly, ciprofloxacin affected notably Sa biofilms under both conditions (adhesion rates declining 4log 
from 1/4MIC to 4MIC), but Ab and Kp biofilms were not disturbed even by the presence of abnormal 
ciprofloxacin concentrations, preserving initial adhesion rates from 106 - 107 cells/cm2/h, respectively. Data 
highlighted that CF unusual species could persist under hypoxia and form biofilms resilient to ciprofloxacin 
currently applied in acute infections, eventually progressing for severe biofilms hard to eradicate with 
powerful antibiotherapy.  
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